Drug Type siRNA |
Synonyms CG LR1, CGLR1 |
Target |
Action inhibitors |
Mechanism ITFG1 inhibitors(integrin alpha FG-GAP repeat containing 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Liver Diseases | Preclinical | United States | 10 Nov 2023 | |
| Fibrosis, Liver | Preclinical | Singapore | 26 Sep 2023 | |
| Liver Cirrhosis | Preclinical | Singapore | 26 Sep 2023 |





